Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,908 | -69,417 | -57,524 | -37,621 | -19,149 |
| Depreciation Amortization | 127 | 1,633 | 1,453 | 940 | 481 |
| Accounts receivable | 246 | -60,738 | -177 | -995 | 189 |
| Other Working Capital | -7,640 | 63,293 | -3,271 | 8,797 | 2,613 |
| Other Operating Activity | -1,593 | 75,451 | 12,916 | 8,084 | 4,534 |
| Operating Cash Flow | $-16,768 | $10,222 | $-46,603 | $-20,795 | $-11,332 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 11,806 | -43,805 | 12,353 | 12,353 | 10,353 |
| PPE Investments | -18 | -2,870 | -3,925 | -3,676 | -1,077 |
| Net Acquisitions | 9,870 | 33,607 | 33,636 | N/A | N/A |
| Investing Cash Flow | $21,658 | $-13,068 | $42,064 | $8,677 | $9,276 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 17,000 | 17,000 | 16,000 | 8,000 |
| Debt Repayment | -2 | -14,357 | -8,277 | -2,238 | -1,932 |
| Common Stock Issued | 134 | N/A | 262 | 5 | 3 |
| Other Financing Activity | -536 | 439 | 150 | 0 | 0 |
| Financing Cash Flow | $-404 | $3,082 | $9,135 | $13,767 | $6,071 |
| Beginning Cash Position | 940 | 704 | 704 | 704 | 704 |
| End Cash Position | 5,426 | 940 | 5,300 | 2,353 | 4,719 |
| Net Cash Flow | $4,486 | $236 | $4,596 | $1,649 | $4,015 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,768 | 10,222 | -46,603 | -20,795 | -11,332 |
| Capital Expenditure | -35 | -2,974 | -4,029 | -3,676 | -1,077 |
| Free Cash Flow | -16,803 | 7,248 | -50,632 | -24,471 | -12,409 |